Matches in SemOpenAlex for { <https://semopenalex.org/work/W2995936880> ?p ?o ?g. }
- W2995936880 endingPage "14" @default.
- W2995936880 startingPage "7" @default.
- W2995936880 abstract "Our main objective was to demonstrate that, in smoker patients hospitalised for Chronic Obstructive Pulmonary Disease (COPD) exacerbation, early initiation of varenicline during 12 weeks, combined with an intensive counselling, is associated with a higher continuous abstainers rate (CAR) at one year as compared to intensive counselling alone. In this multicenter, prospective, double-blind, randomised study, 81 smoking COPD patients hospitalised for an acute exacerbation for at least 24 h were allocated to receive either varenicline (n = 42) or placebo (n = 39) for 12 weeks, in association with an intensive counselling in the 2 groups, and followed up for 40 weeks. The primary outcome was CAR at week 52. Secondary outcomes included CAR at week 12 and 26, partial abstinence rate (PAR) at week 12, 26 and 52, nicotinic substitute consumption and adverse events. At week 52, CAR was not different in placebo and varenicline groups (25.6%). At week 12, CAR was significantly higher in the varenicline group (50%) as compared to placebo group (27%) (p = 0.041). Nicotine consumption was significantly higher at week 52 in the placebo group (55.3%) as compared to the varenicline group (24.4%) (p = 0.005). There was no significant difference in PAR at week 12, 26 and 52; the frequency of adverse events was similar between the two groups. Among active smoker COPD patients with exacerbation, 12-week varenicline associated with intensive counselling for smoking cessation increased the rate of continuous abstainers as compared to placebo. However, benefit was not maintained after varenicline discontinuation.Clinical Trials Registration: URL: http://www.controlled-trials.com. Unique identifier: NCT01694732" @default.
- W2995936880 created "2019-12-26" @default.
- W2995936880 creator A5001192345 @default.
- W2995936880 creator A5004194543 @default.
- W2995936880 creator A5010354313 @default.
- W2995936880 creator A5012888781 @default.
- W2995936880 creator A5027618522 @default.
- W2995936880 creator A5032459124 @default.
- W2995936880 creator A5038839524 @default.
- W2995936880 creator A5042288231 @default.
- W2995936880 creator A5044292496 @default.
- W2995936880 creator A5045010479 @default.
- W2995936880 creator A5047851511 @default.
- W2995936880 creator A5051922597 @default.
- W2995936880 creator A5059468579 @default.
- W2995936880 creator A5061551115 @default.
- W2995936880 creator A5070498798 @default.
- W2995936880 creator A5074387792 @default.
- W2995936880 creator A5091625201 @default.
- W2995936880 date "2019-12-19" @default.
- W2995936880 modified "2023-10-15" @default.
- W2995936880 title "Effect of Early Initiation of Varenicline on Smoking Cessation in COPD Patients Admitted for Exacerbation: The Save Randomized Clinical Trial" @default.
- W2995936880 cites W1965632753 @default.
- W2995936880 cites W1981378561 @default.
- W2995936880 cites W2020171179 @default.
- W2995936880 cites W2054931962 @default.
- W2995936880 cites W2055445378 @default.
- W2995936880 cites W2082069875 @default.
- W2995936880 cites W2085024523 @default.
- W2995936880 cites W2100803003 @default.
- W2995936880 cites W2101081697 @default.
- W2995936880 cites W2107200746 @default.
- W2995936880 cites W2109535127 @default.
- W2995936880 cites W2128299591 @default.
- W2995936880 cites W2131454732 @default.
- W2995936880 cites W2135501737 @default.
- W2995936880 cites W2144862531 @default.
- W2995936880 cites W2160161905 @default.
- W2995936880 cites W2163267243 @default.
- W2995936880 cites W2164386461 @default.
- W2995936880 cites W2166432084 @default.
- W2995936880 cites W2340896985 @default.
- W2995936880 cites W2361945527 @default.
- W2995936880 cites W2470095143 @default.
- W2995936880 cites W2780716234 @default.
- W2995936880 cites W3118452870 @default.
- W2995936880 cites W4236896289 @default.
- W2995936880 cites W4320288047 @default.
- W2995936880 doi "https://doi.org/10.1080/15412555.2019.1703928" @default.
- W2995936880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31854207" @default.
- W2995936880 hasPublicationYear "2019" @default.
- W2995936880 type Work @default.
- W2995936880 sameAs 2995936880 @default.
- W2995936880 citedByCount "13" @default.
- W2995936880 countsByYear W29959368802020 @default.
- W2995936880 countsByYear W29959368802021 @default.
- W2995936880 countsByYear W29959368802022 @default.
- W2995936880 countsByYear W29959368802023 @default.
- W2995936880 crossrefType "journal-article" @default.
- W2995936880 hasAuthorship W2995936880A5001192345 @default.
- W2995936880 hasAuthorship W2995936880A5004194543 @default.
- W2995936880 hasAuthorship W2995936880A5010354313 @default.
- W2995936880 hasAuthorship W2995936880A5012888781 @default.
- W2995936880 hasAuthorship W2995936880A5027618522 @default.
- W2995936880 hasAuthorship W2995936880A5032459124 @default.
- W2995936880 hasAuthorship W2995936880A5038839524 @default.
- W2995936880 hasAuthorship W2995936880A5042288231 @default.
- W2995936880 hasAuthorship W2995936880A5044292496 @default.
- W2995936880 hasAuthorship W2995936880A5045010479 @default.
- W2995936880 hasAuthorship W2995936880A5047851511 @default.
- W2995936880 hasAuthorship W2995936880A5051922597 @default.
- W2995936880 hasAuthorship W2995936880A5059468579 @default.
- W2995936880 hasAuthorship W2995936880A5061551115 @default.
- W2995936880 hasAuthorship W2995936880A5070498798 @default.
- W2995936880 hasAuthorship W2995936880A5074387792 @default.
- W2995936880 hasAuthorship W2995936880A5091625201 @default.
- W2995936880 hasConcept C118552586 @default.
- W2995936880 hasConcept C126322002 @default.
- W2995936880 hasConcept C142724271 @default.
- W2995936880 hasConcept C168563851 @default.
- W2995936880 hasConcept C197934379 @default.
- W2995936880 hasConcept C204787440 @default.
- W2995936880 hasConcept C27081682 @default.
- W2995936880 hasConcept C2776780178 @default.
- W2995936880 hasConcept C2777014857 @default.
- W2995936880 hasConcept C2777053506 @default.
- W2995936880 hasConcept C2777843972 @default.
- W2995936880 hasConcept C2778715236 @default.
- W2995936880 hasConcept C2779547902 @default.
- W2995936880 hasConcept C2780687700 @default.
- W2995936880 hasConcept C42219234 @default.
- W2995936880 hasConcept C71924100 @default.
- W2995936880 hasConceptScore W2995936880C118552586 @default.
- W2995936880 hasConceptScore W2995936880C126322002 @default.
- W2995936880 hasConceptScore W2995936880C142724271 @default.
- W2995936880 hasConceptScore W2995936880C168563851 @default.
- W2995936880 hasConceptScore W2995936880C197934379 @default.
- W2995936880 hasConceptScore W2995936880C204787440 @default.